FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
WASHINGTON, D.C. — The U.S. Food and Drug Administration granted approval to Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate) capsules, co-packaged for oral …
Read More